Welcome to the G-FINDER survey

The G-FINDER survey tracks annual investment into R&D for new products and technologies to addres priority global health challenges. This includes basic research and the development of new drugs, vaccines, diagnostics and other tools for global health priorities that disproportionately affect people in low- and middle-income countries, including neglected diseases (NDs), emerging infectious diseases (EIDs) and sexual and reproductive health (SRH) issues.

The survey is conducted by Policy Cures Research and funded by the Bill & Melinda Gates Foundation. For more information, please refer to the frequently asked questions.

As part of the ongoing evolution and improvement of the G-FINDER project, we have made the following changes to the survey scope:

In light of the COVID-19 pandemic, we are also collecting funding data for COVID-19 basic research and product development. We note that this is unlikely to fall in your 2019 financial year, but in a rapidly changing environment, we are striving to supplement our tracking of publicly announced funding commitments with confirmed disbursement data. Please provide the date of any disbursements you made, and if applicable what candidate or clinical trial it was for, in the notes column of the survey.


Before you start the survey



G-FINDER reports and data portal

Our unique database of R&D investment data for global health issues can be freely accessed through the G-FINDER data portal.

Our analysis and reports based on this data can be found here.


Key dates


14 June 2019
Deadline for completing the survey

SURVEY CLOSED

0 days left to complete the survey.